Madden Martin J. 4
4 · NovoCure Ltd · Filed Jun 11, 2021
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Madden Martin J.
Director
Transactions
- Award
Options to Buy Ordinary Shares
2021-06-09+1,499→ 1,499 totalExercise: $211.89Exp: 2031-06-09→ Ordinary Shares (1,499 underlying) - Award
Restricted Stock Units
2021-06-09+814→ 15,620 total
Holdings
- 418(indirect: Indirect)
Ordinary Shares
Footnotes (3)
- [F1]These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (1) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2022 annual general meeting of shareholders.
- [F2]Represents shares indirectly beneficially owned by Mr. Madden that are held by his child with whom he shares a residence. Mr. Madden disclaims beneficial ownership of these shares.
- [F3]Options to buy 1,499 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2022 annual general meeting of shareholders.